摘要
目的:为我国基本药物的遴选和调整提供参考。方法:通过查阅世界卫生组织(WHO)系列技术报告,运用文献研究和比较研究方法进行分析。结果:WHO基本药物示范目录的遴选原则经多次补充完善,使得基本药物的遴选由经验决策转变为循证决策,剂型和规格更加规范,修订后的目录修订程序更加符合循证、公正和透明的原则。结论:我国应借鉴WHO的经验,完善符合我国国情的基本药物目录遴选和调整原则,完善基本药物制度体系。
OBJECTIVE: To put forward some suggestions for the selection and revision of essential medicines in China. METHODS: Reviewed WHO series technical reports, literatures study and comparison method was adopted. RESULTS: The selec- tion criteria for WHO Model List of Essential Medicines had been revised for several times, which made the selection of essential medicines change from experience-based decisions to evidence-based decision, dosage forms and specification were more standard, the new update and dissemination procedure was more consistent with the evidence-based, transparent and justice principle. CON- CLUSION: We should learn from WHO's experience, develop our own selection criteria of essential medicines and improve essen- tial medicine system in China.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第28期2593-2597,共5页
China Pharmacy
基金
中国/世界卫生组织2010-2011年度正规预算合作项目(WPCHN1004601)
关键词
基本药物
遴选
原则
进展
Essential medicines
Selection
Princople
Development